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The importance of maternal folate consumption for
normal development is well established, yet the
molecular mechanism linking folate metabolism to
development remains poorly understood. The
enzyme methionine synthase reductase (Mtrr) is
necessary for utilization of methyl groups from the
folate cycle. We found that a hypomorphic mutation
of the mouseMtrr gene results in intrauterine growth
restriction, developmental delay, and congenital
malformations, including neural tube, heart, and
placental defects. Importantly, these defects were
dependent upon the Mtrr genotypes of the maternal
grandparents. Furthermore, we observed wide-
spread epigenetic instability associated with altered
gene expression in the placentas of wild-type grand-
progeny of Mtrr-deficient maternal grandparents.
Embryo transfer experiments revealed thatMtrr defi-
ciency in mice lead to two distinct, separable pheno-
types: adverse effects on their wild-type daughters’
uterine environment, leading to growth defects in
wild-type grandprogeny, and the appearance of
congenital malformations independent of maternal
environment that persist for five generations, likely
through transgenerational epigenetic inheritance.INTRODUCTION
It is well established that maternal folate deficiency or polymor-
phisms in genes required for folate metabolism are associated
with an increased risk of congenital abnormalities in humans,
including intrauterine growth restriction, cardiovascular and
placental abnormalities, and neural tube defects (NTDs). How-ever, conflicting reports have been published showing associa-
tion and nonassociation between polymorphisms in folate
pathway genes and risk for specific congenital malformations
(e.g., NTDs [Rampersaud et al., 2003; van der Put et al., 1995]).
This is reinforced by studies whereby mutations in mouse genes
encoding proteins required for folate transport and metabolism
do not appear to recapitulate the range of congenital abnormal-
ities produced by maternal folate deficiency in humans (Chen
et al., 2001; Deng et al., 2008; Gelineau-van Waes et al., 2008;
Pickell et al., 2009; Piedrahita et al., 1999; Swanson et al.,
2001). As a result, the underlying mechanism through which
folate metabolism acts during development may be more com-
plex than once thought and remains poorly understood.
Folate is a carrier of methyl groups destined for downstream
targets, including homocysteine for methionine synthesis in a
reaction that links the folate and methionine cycles (Figure 1A).
The main circulating folate, 5-methyltetrahydrofolate (5-methyl-
THF) (Smith et al., 2006), is generated bymethylenetetrahydrofo-
late reductase (MTHFR) (Ghandour et al., 2004; Hart et al., 2002).
Its methyl group is exclusively transferred by methionine syn-
thase (MS, encoded by the gene Mtr) to homocysteine to form
methionine and tetrahydrofolate (Shane and Stokstad, 1985).
In turn, methionine is a precursor to S-adenosylmethionine
(S-AdoMet), which serves as the methyl donor for dozens of
cellular substrates, including proteins, RNA, and DNA (Ghandour
et al., 2002; Jacob et al., 1998; Wainfan et al., 1975). Conse-
quently, folate andmethioninemetabolism are important for suc-
cessful pregnancy. In mammals, methionine synthase reductase
(Mtrr) is responsible for the activation of MS through the reduc-
tive methylation of its vitamin B12 cofactor (Yamada et al.,
2006). Therefore, Mtrr is required for normal progression of the
folate and methionine cycles.
Here, we demonstrate that a hypomorphic mutation in the
mouse Mtrr gene (Mtrrgt) disrupts folate metabolism. Remark-
ably, through a series of highly controlled genetic pedigrees,
we show that the Mtrrgt allele is associated with effects on
offspring development that are transmitted transgenerationally.Cell 155, 81–93, September 26, 2013 ª2013 Elsevier Inc. 81
Figure 1. Mtrrgt Is a Knockdown Mutation
Resulting in Hyperhomocysteinemia
(A) Diagram of folate andmethioninemetabolisms.
(B) b-geo gt containing a splice-acceptor (SA) and
polyadenylated (pA) tail was randomly inserted
into intron 9 of theMtrr gene to produce theMtrrgt
allele. PCR primers flanking the gt insertion site
(arrows b and c) in combination with a primer an-
nealing to the gt (arrow a) discerned theMtrr+ and
Mtrrgt alleles.
(C) qRT-PCR analysis of wild-type Mtrr mRNA
levels (mean ± SEM) in adult organs (n = 5 organs/
genotype) from Mtrr+/+, Mtrr+/gt, and Mtrrgt/gt
mice derived from Mtrr+/gt intercrosses compared
to C57Bl/6 mice. Data are presented as fold
difference compared to C57Bl/6 controls
(normalized to 1).
(D) Plasma total homocysteine concentrations
(mm; mean ± SD) in Mtrr+/+, Mtrr+/gt, and Mtrrgt/gt
adult mice compared to C57Bl/6 adults (n = 3–8
mice/bar). Statistical analysis: independent com-
parison of each genotype to C57Bl/6 mice using
a t test. *p < 0.05, **p < 0.01, and ***p < 0.005.
See also Table S4.In particular, the Mtrr genotype of either maternal grandparent
dictates the developmental potential of their wild-type grand-
progeny. These effects are associated with altered DNA methyl-
ation patterns and two distinct phenotypes: intrauterine growth
defects and congenital malformations that are separable
through embryo transfer experiments. We propose that the
Mtrr mutant mouse line provides a robust model for studying
epigenetic transmission of developmental disorders between
generations.
RESULTS
Mtrrgt Mutation Causes Abnormal Folate Metabolism in
Mice
To explore the relationship between folate metabolism and
development, we generated Mtrr-deficient mice using embry-
onic stem cells containing a randomly inserted gene-trap (gt)
vector in theMtrr gene locus (Figure 1B).We verified the insertion
of the gt vector into intron 9 of theMtrr locus by Southern blotting
and DNA sequencing (data not shown) and were able to distin-
guish between Mtrr+/+, Mtrr+/gt, and Mtrrgt/gt mice by a three
primer PCR using primers that flanked the gt insertion site com-
bined with a primer specific to the gt vector (Figure 1B).82 Cell 155, 81–93, September 26, 2013 ª2013 Elsevier Inc.To test whether transcription of wild-
type Mtrr mRNA was disrupted in our
model, we performed quantitative RT-
PCR (qRT-PCR) on RNA collected from
adult tissues of Mtrr+/+, Mtrr+/gt, and
Mtrrgt/gt mice. Despite the gt insertion,
we detected wild-type messenger RNA
(mRNA) transcripts in all Mtrrgt/gt tissues
tested, albeit at 19.3%–35.7% of Mtrr+/+
levels (Figure 1C), which is indicative of
splicing around the gt in some tran-scripts. Mtrr+/gt tissues contained 49.0%–66.8% of Mtrr+/+
mRNA levels (Figure 1C). As a result,Mtrrgt is a knockdown allele.
Increased levels of plasma homocysteine are used as an indi-
cator of folate deficiency (Hague, 2003; Piedrahita et al., 1999).
Therefore, using tandem mass spectrometry, we measured
plasma total homocysteine concentrations in adult female and
male Mtrrgt/gt mice and detected an average of 23.3 ± 5.5 mM
(mean ± SD) and 11.0 ± 3.6 mM total homocysteine, respectively.
These values were 3.3- to 3.7-fold greater than in Mtrr+/+ litter-
mates (females: 7.0 ± 0.6 mM [p < 0.005]; males: 4.6 ± 0.3 mM
[p < 0.05]) (Figure 1D) and are comparable to mouse models
with genetic mutations in other folate metabolic enzymes (sum-
marized by Elmore et al., 2007). Elmore et al. (2007) also showed
increased liver 5-methyl-THF, reduced plasma methionine, and
reduced heart AdoMet/AdoHcy ratio in Mtrr-deficient adults
compared to wild-type littermates. Altogether, these data reveal
thatMtrrgtmice are an appropriate model for studying the impact
of abnormal folate metabolism.
Phenotypes of Progeny from Mtrr+/gt Intercrosses Do
Not Correlate with Embryonic Genotypes
Analysis of the progeny from Mtrr+/gt intercrosses revealed a
normal Mendelian ratio at weaning age (36:56:23), indicating
Figure 2. Phenotypes of Progeny from
Mtrr+/gt Intercrosses at E10.5 Do Not Corre-
late with Embryonic or Maternal Genotypes
(A and B) Phenotypic frequencies in litters from (B)
Mtrr+/gt intercrosses compared to (A) C57Bl/6
crosses denoted by the average number of con-
ceptuses/litter (±SEM) followed by the percentage
of total conceptuses in brackets. Statistical anal-
ysis: independent comparison of phenotypic fre-
quencies from Mtrr+/gt intercrosses compared to
C57Bl/6 using Mann-Whitney test. *p < 0.05, **p <
0.01, and ***p < 0.001.
(C) Phenotypic frequency in each embryonic ge-
notype derived from Mtrr+/gt intercrosses. No sig-
nificant difference between embryonic genotypes
(Fisher’s exact test).
(D–Q) Representative images of conceptuses at
E10.5. Embryonic genotype is indicated. (D)
Normal-appearing embryo compared to (E and F)
developmentally delayed embryos resembling (E)
E9.5- and (F) E8.5-staged embryos. (G–J)
Embryos with heart defects including (G) pericar-
dial edema (arrow) or (J) enlarged heart (arrow) and
small branchial arches (arrowhead). (H) Normal
leftward cardiac looping versus (I) abnormal
rightward cardiac looping (dotted line). (K–L) Pla-
centas with (K) normal centered or (L) abnormal
off-centered allantois attachment (arrowhead). (M
and N) Hemorrhage (arrow) in (M) placenta or (N)
embryo. (O) Normal neural tube closure versus
(P and Q) open neural tubes (arrowhead) in the (P)
cranial or (Q) spinal cord regions. Scale bars: (D)–
(H) and (K)–(Q), 1 mm; (I) and (J), 0.5 mm.
(R) Phenotypic frequencies per litter (generation III)
from designated crosses at E10.5. Grandparent
genotypes were determined retrospectively. Third
pedigree from the left: maternal grandfather was
Mtrr+/+ or Mtrr+/gt. Pedigrees: circle, female;
square, male; blue outline, C57Bl/6 line; black
outline, Mtrr line; white fill, Mtrr+/+; half black/half
white, Mtrr+/gt; black fill, Mtrrgt/gt.
See also Figure S1 and Table S1.that Mtrrgt/gt mice are viable. We observed no obvious pheno-
types in Mtrrgt/gt adult mice. However, we noticed that the litter
sizes were smaller (5.8 pups/litter, n = 20 litters) compared to
control C57Bl/6 litters with the same genetic background as
the Mtrrgt mouse line (8.3 pups/litter, n = 8 litters). Therefore,
embryos of Mtrr+/gt intercrosses were analyzed during gesta-
tion. At embryonic (E) day 10.5, 55.5% of conceptuses from
Mtrr+/gt parents were normal (Figure 2B), in contrast to 95.7%
of the conceptuses from C57Bl/6 litters (Figure 2A). Similar
numbers of resorptions were present, suggesting that there
was no difference in embryonic lethality occurring prior to
E10.5. However, the remaining conceptuses from the mutant
matings showed severe congenital malformations not present
in control litters, ranging from developmental delay to NTDs
and heart defects. Surprisingly and consistent with Mendelian
ratios at weaning, genotyping results indicated that all embry-onic genotypes, including wild-type, were equally affected
(Figure 2C).
We found that 20% of embryos at E10.5 were developmen-
tally delayed by 0.5–2.0 days (i.e., contained <30 somite pairs)
(Figures 2B, 2E, and 2F and Table S1 available online), although
they otherwise appeared normal. In addition, 12.9% of concep-
tuses exhibited one or more congenital abnormality (Figure 2
and Table S1). Among these, we observed heart defects,
including pericardial edema (Figure 2G), reversed cardiac loop-
ing (Figure 2I) and enlarged hearts that were thicker and dispro-
portionate in size (Figure 2J), abnormal placental development
whereby chorioallantoic attachment was eccentric (Figure 2L)
or failed to occur (data not shown), and hemorrhaging (Figures
2M and 2N). NTDs were also observed, including neural tubes
that failed to close by the appropriate developmental stage in
the cranial region (Figure 2P). These defects are reminiscentCell 155, 81–93, September 26, 2013 ª2013 Elsevier Inc. 83
Figure 3. Maternal Grandparental Mtrr Ge-
notypes Are Important for a Successful
Pregnancy
(A–E) (A and B) Phenotypic frequencies caused by
Mtrr+/gt maternal grandmothers (MGMs) or
grandfathers (MGFs) at E10.5 compared to C57Bl/
6 controls.Mtrr+/gt paternal andMtrrgt/gt pedigrees
were also assessed. Data are represented as (A)
number of conceptuses/litter with a specific
phenotype and (B) average number of phenotypi-
cally affected conceptuses/litter (± SEM) followed
by the percentage of total conceptuses in
brackets. Colored boxes in (B) indicate the pedi-
grees assessed in (C) and (E). Pedigrees: circle,
female; square, male; blue outline, C57Bl/6 mice;
black outline, Mtrr mouse line; white fill, Mtrr+/+;
half black/half white fill,Mtrr+/gt; black fill,Mtrrgt/gt.
Statistics: independent comparison of phenotypic
frequencies per litter of each pedigree and C57Bl/
6 using Mann-Whitney test.
(C) Average embryo crown-rump lengths (± SEM)
(left) and average placental weights (± SEM) (right)
from conceptuses staged as E10.5 (i.e., 30–40
somite pairs) per pedigree (n = 51–89 concep-
tuses). Statistics: comparison to C57Bl/6 using
independent t test.
(D) Representative images of normal, growth-
restricted (GR) and growth-enhanced (GE) wild-
type embryos at E10.5. Scale bars, 1 mm.
(E) Distribution of crown-rump lengths in E10.5-
staged embryos (n = 51–89 embryos). Black
dotted line, mean; gray dotted lines, two SD from
mean. *p < 0.05, **p < 0.01, and ***p < 0.005. See
also Figure S2 and Table S2.of embryos at E10.5 from Mthfr+/ intercrosses (Pickell et al.,
2009).
Mtrr Deficiency in Either Maternal Grandparent Is
Sufficient to Cause Defects in Their Wild-Type
Grandprogeny at E10.5
Given that all embryonic genotypes from Mtrr+/gt intercrosses
were similarly affected, we suspected that a parental or even
grandparental Mtrrgt mutation might affect development. In our
initial studies, most of the mice were generated from Mtrr+/gt in-
tercrosses, including Mtrr+/+ controls. This became important
when we found that the same types of abnormal conceptuses
were observed at a high frequency (44/102 conceptuses) from
Mtrr+/+ females crossed to Mtrr+/+ males at E10.5 (Figure S1).
Pedigree analysis of these Mtrr+/+ intercrosses revealed that84 Cell 155, 81–93, September 26, 2013 ª2013 Elsevier Inc.pregnancies with abnormal litters almost
always had Mtrr+/gt maternal grandpar-
ents (Figures 2R and S1). This implied
that normal embryonic development
might be associated with a grandpa-
rental, and not parental, Mtrrgt mutation.
To verify that a paternalMtrrgt allele did
not contribute to the defects, we crossed
Mtrr+/gt males with C57Bl/6 females and
assessed the litters at E10.5 (n = 10 litters)(Figures 3A, 3B, and S2). All conceptuses were normal with no
obvious developmental delay or defects, except one conceptus
with a placenta defect. Because theMtrr+/gt males were derived
from Mtrr+/gt parents, these data indicated that neither the
paternal nor the paternal grandparents’ Mtrr genotype signifi-
cantly affected development at this stage.
Next, we examined the specific effect of the maternal grand-
parentalMtrrgt mutation on embryonic development by crossing
Mtrr+/gt females with C57Bl/6 males or C57Bl/6 females with
Mtrr+/gtmales (generation I).Mtrr+/+ daughters from the resulting
litters were then crossed with C57Bl/6 males (generation II). The
subsequent Mtrr+/+ litters (generation III) were dissected at
E10.5, and the conceptuses were assessed for abnormalities
(Figures 3A and 3B). Only 39.0% of conceptuses derived from
Mtrr+/gt maternal grandmothers and 47.2% of the conceptuses
derived from Mtrr+/gt maternal grandfathers appeared normal
(Figure 3B). Crown-rump length measurements of embryos
within the normal developmental range for E10.5 (30–40 somite
pairs) revealed that, on average, these embryos were signifi-
cantly smaller than C57Bl/6 embryos (Figure 3C). In fact, a large
proportion of these so-called ‘‘normal’’ embryos were growth
restricted (22.0% and 22.5% of conceptuses from Mtrr+/gt
maternal grandmothers and grandfathers, respectively, as de-
fined as more than two SDs below the mean length of C57Bl/6
embryos) (Figures 3D and 3E). However, some embryos were
actually growth enhanced, particularly those derived from Mtrr-
deficient maternal grandfathers (7.9% growth enhanced, p <
0.05) (Figures 3B, 3D, and 3E). The presence of growth pheno-
types did not correlate with litter size (Table S2). Beyond growth
defects, the remaining affected conceptuses were either devel-
opmentally delayed or had severe defects (Figures 3A and 3B),
similar to those described above, including NTDs, heart abnor-
malities, placental defects, and hemorrhages (Figure S2). The
rates of resorption were not significantly different from C57Bl/6
controls (Figure 3B). Interestingly, some litters were more sensi-
tive to grandparentalMtrr deficiency than others because a pro-
portion of the litters appeared normal, whereas up to 100% of
conceptuses were affected in other litters (Figure 3A).
Mtrrgt/gt conceptuses derived from pedigrees with Mtrrgt/gt
parents and grandparents were also assessed (n = 21 litters).
These litters showed similar phenotypes but at a higher fre-
quency compared to Mtrr+/+ conceptuses derived from an
Mtrr+/gt maternal grandparent (Figures 3 and S2), suggesting a
dose-dependent effect of the Mtrrgt allele. The growth pheno-
type was not assessed in the initial Mtrr+/gt intercrosses or
maternal effect pedigrees, which is why the percentage of the
conceptuses categorized as phenotypically ‘‘normal’’ is different
in these pedigrees (Figures 2 and S1 and Table S1) compared to
the pedigrees showing a maternal grandparental origin effect
(Figures 3 and S2).
Combined, these data implied that anMtrrgt mutation in either
maternal grandparent disrupted the development of their grand-
progeny, even when the parents and the conceptus were wild-
type. Importantly, the effect was not exacerbated when both
the maternal grandmother and mother carried the Mtrrgt allele
or when both the maternal grandfather and mother carried the
Mtrrgt allele (Figures 3 and S2). This indicates that the presence
of theMtrrgt mutation in either maternal grandparent is sufficient
to produce developmental phenotypes in their wild-type
grandprogeny.
Mtrr Deficiency Causes Tissue-Specific Global DNA
Hypomethylation
Because disruption of the folate cycle is thought to inhibit the
transmission of one-carbon methyl groups necessary for DNA
methylation, global DNA methylation levels were measured in
the Mtrrgt model. Livers and nonpregnant uteri from Mtrr+/gt
and Mtrrgt/gt adult mice showed a significant reduction in DNA
methylation (44.9%–74.2% of C57Bl/6 levels) (Figure 4A). Inter-
estingly, DNA methylation in Mtrr+/gt and Mtrrgt/gt adult brains
was not significantly different from controls (Figure 4A), indi-
cating that the brain might be spared from reducedmethyl group
availability. DNA hypomethylation was also evident in the liversand uteri of adult wild-type littermates (40%–62% of C57Bl/6
levels; Figure 4A), further emphasizing a nongenetic influence
in the Mtrrgt model. These data support an epigenetic effect of
folate metabolism because the dysregulation of DNA methyl-
ation precedes the appearance of developmental phenotypes
in the Mtrrgt model.
Next, we assessed the effects of maternal grandparental Mtrr
deficiency on global DNA methylation in their wild-type grand-
progeny at E10.5. Although we did not observe significant differ-
ences in the phenotypically normal or growth-restricted embryos
derived from an Mtrr+/gt maternal grandparent, there was signif-
icant global DNA hypomethylation in the corresponding
placentas (53% or 63%–66% of C57Bl/6 levels, respectively)
(Figure 4C). This implied that the placental epigenetic landscape
was altered. Global DNA methylation was also reduced in wild-
type placentas derived from Mtrr+/gt fathers (50% of C57Bl/6
levels) (Figure 4C), which further supports an epigenetic mecha-
nism because it shows that altered DNA methylation precedes
the appearance of developmental phenotypes. For example,
wild-type daughters of an Mtrr+/gt male developed normally
despite having hypomethylated placental DNA, and yet in adult-
hood, these females produce abnormal progeny with hypome-
thylated placentas (Figures 3A, 3B, and 4C).
Placentas of Wild-Type Grandprogeny Are
Epigenetically Unstable at E10.5
Imprinted loci have previously been used as a model to study
epigenetic stability during development (Messerschmidt et al.,
2012). It is well known that imprinted genes are regulated by
DNA methylation at differentially methylated regions (DMRs)
in a parental-origin specific manner. The majority of known
imprinted genes is expressed in fetally derived extraembryonic
tissue within the placenta and not in the maternal decidua and
is required for normal placental development (Coan et al.,
2005; Hemberger, 2010; Tunster et al., 2013). To determine the
degree of epigenetic instability in grandprogeny of an Mtrr+/gt
maternal grandparent, we analyzed imprinted loci for alterations
in DNA methylation and gene expression in wild-type placentas
at E10.5.
Using the bisulfite pyrosequencingmethod, we assessed DNA
methylation at key CpG sites (n = 143) within 20 different DMRs
(Table S3). Analysis of placentas of wild-type conceptuses
derived from Mtrr+/gt fathers revealed only a few CpG sites (10/
143 CpGs in 6/20 DMRs) that were significantly abnormally
methylated with an average methylation change (± SEM) of
2.0% ± 0.2% compared to C57Bl/6 levels (Figures 4D, 4E, and
5 and Table S3). This implied that these placentas were epige-
netically quite stable, which is consistent with the absence of
phenotypes in these litters (Figure 3). Conversely, a large propor-
tion (45.0%–70.0%) of the DMRs assessed in wild-type pla-
centas of phenotypically normal, growth-restricted, and severely
affected grandprogeny derived from either Mtrr+/gt maternal
grandparent had CpG site methylation levels that were statisti-
cally different from C57Bl/6 (Figures 4E and 5 and Table S3).
The majority of the significantly affected CpG sites were hyper-
methylated (Figure 4F). The placentas of growth-restricted and
severely affected conceptuses had an average CpGmethylation
change that was significantly larger (5.4%–5.5% [p < 0.05] andCell 155, 81–93, September 26, 2013 ª2013 Elsevier Inc. 85
Figure 4. Placentas of Wild-Type Grand-
progeny Display Epigenetic Instability at
E10.5
(A) Global 5mC levels (mean ± SEM) in adult
tissues from Mtrr+/+, Mtrr+/gt, and Mtrrgt/gt mice
relative to C57Bl/6 (n = 4–18 mice; normalized
to 1).
(B) Each box denotes the pedigree from which
conceptuses analyzed in panels (C) and (D) were
derived and their phenotype (normal [n], growth-
restricted [gr], and severely affected [a]).
(C) Relative global 5mC levels (mean ± SEM) in
placentas and embryos derived from the pedigree
denoted in (B) compared to C57Bl/6 (n = 5–10;
normalized to 1). Independent t tests compared
C57Bl/6 to each phenotype/pedigree.
(D) Average change in CpG methylation (%) in
imprinted DMRs compared to C57Bl/6 controls
(± SEM). Placentas of conceptuses derived from
the pedigree denoted in (B) were assessed. Only
CpG sites with significant methylation changes
were included. Growth-restricted and severely
affected placentas were compared to phenotypi-
cally normal placentas within the same pedigree
using an independent t test.
(E) A heatmap indicating average methylation
change (%) at individual CpG sites in each DMR
compared to C57Bl/6. Placentas of phenotypically
normal (n), growth-restricted (gr) and severely
affected (a) conceptuses (generation III) from each
pedigree were assessed.
(F and G) The number of (F) DMRs with significant
hyper- or hypomethylation and (G) imprinted
genes with significant up- or downregulated RNA
expression in placentas of conceptuses from the
designated pedigree and phenotypic group
compared to C57Bl/6.
(H) An association analysis between CpG methyl-
ation in DMRs and RNA expression of corre-
sponding imprinted genes. Abnormal DMR
methylation: R 1 CpG site with significantly
different methylation compared to C57Bl/6.
Abnormal RNA expression: significantly different
from C57Bl/6. n = 3–10 placentas/phenotype/
pedigree in panels (C)–(H). Ab, abnormal; Exp,
expression; Meth, methylation; N, normal. xp =
0.07, *p < 0.05, **p < 0.01, and ***p < 0.005.
See also Figure S3 and Table S3.6.6%–7.2% [p < 0.005] of C57Bl/6 levels, respectively)
compared to phenotypically normal conceptuses from the
same pedigree (3.0%–3.3% of C57Bl/6 levels) (Figures 4D and
5 and Table S3), indicating a positive correlation between epige-
netic instability and the severity of the phenotype. Furthermore,
some DMRs were more sensitive to grandparental Mtrr defi-
ciency than others because a proportion had only one CpG
site with significantly aberrant methylation, whereas other
DMRs had up to 100% of CpG sites with abnormal methylation
that were statistically different from C57Bl/6 controls (Fig-
ure S3A). These overall DNA methylation trends were further
exacerbated in Mtrrgt/gt placentas (Figures 4D–4F, 5, and S3A
and Table S3).
To determine whether the placental epigenetic instability
observed was functionally important, we used qRT-PCR tomea-86 Cell 155, 81–93, September 26, 2013 ª2013 Elsevier Inc.sure the expression of imprinted genes specifically regulated by
methylation at these DMRs in the grandprogeny at E10.5 (Table
S3). The majority of misexpressed genes was statistically down-
regulated in a phenotype-dependent manner compared to
C57Bl/6 placentas (Figure 4G and Table S3), which supports
the overall trend of DMR hypermethylation. Importantly, more
misexpressed genes were associated with abnormal DMR
methylation rather than normal DMR methylation. This occurred
regardless of the conceptus’ phenotype and whether it was
derived from an Mtrr+/gt maternal grandmother or grandfather
(Figures 4H and 5). Together with the observation that there
were a considerable number of abnormally methylated DMRs
associated with normally expressed genes (Figure 4H), we
conclude that dysregulation of DNA methylation likely preceded
the changes in gene expression. The instances of gene
misexpression associated with normal DMR methylation (Fig-
ure 4H) were likely the consequence of secondary effects of
Mtrr deficiency, including the dysregulation by upstream genes
affected by abnormal methylation (e.g., transcription factors or
noncoding RNA). Altogether, this suggests a hierarchy of events:
anMtrrgtmutation in either maternal grandparent leads to epige-
netic instability in important regulatory regions in placentas of
their wild-type grandprogeny, which may, in turn, cause gene
misexpression leading to developmental phenotypes.
As with the global methylation patterns, DMRmethylation and
gene expression (e.g., the Igf2/H19 locus) in wild-type embryos
at E10.5 was not significantly different from controls (Figures
4C and S3B and Table S3). Important changes in DNA methyl-
ation and gene expression of specific cell populations might
not be apparent when assessing whole embryos. Alternatively,
placental cells may be more susceptible than embryonic cells
to the intergenerational effects of abnormal folate metabolism.
A direct paramutation effect (Rassoulzadegan et al., 2006) is un-
likely because normal levels of wild-type Mtrr mRNA were pre-
sent in Mtrr+/+ placentas and embryos at E10.5 derived from
either an Mtrr+/gt parent or grandparent compared to C57Bl/6
controls, regardless of phenotype (Figure S4).
Congenital Abnormalities in Wild-Type Grandprogeny
Are due to Epigenetic Inheritance
To better understand the causes of the developmental abnor-
malities observed in the grandprogeny, we performed an embryo
transfer experiment (Figures 6 and S5) to distinguish between an
epigenetic effect on the ability of females in generation II to carry
normal pregnancies (maternal environment) versus the effect on
gametes (direct epigenetic inheritance). Wild-type preimplanta-
tion embryos derived from pedigrees with one Mtrr+/gt maternal
grandparent and a wild-type mother were collected at E3.25,
immediately prior to the initiation of DNA remethylation during
epigenetic reprogramming (Saitou et al., 2012). Same-stage
C57Bl/6 embryos were used as controls. Embryos were trans-
ferred into the uteri of pseudopregnant B6D2F1 females and
allowed to develop until E10.5. If a phenotype was absent,
then an abnormal maternal environment in the original donor
mother (i.e., generation II) was the cause of this defect. However,
persistence of a phenotype indicates that this defect occurred
independent of the maternal environment.
Remarkably, the embryo transfer results suggested that the
growth defects and the congenital malformations were due to
separate epigenetic mechanisms. Growth restriction and devel-
opmental delay phenotypes were not observed in the transferred
litters derived from Mtrr+/gt maternal grandmothers (n = 36 con-
ceptuses) and Mtrr+/gt maternal grandfathers (n = 60 concep-
tuses) (Figures 6 and S5), indicating that the B6D2F1 maternal
environment rescued the growth phenotypes. In fact, we
observed an increased frequency of growth enhancement
(16.7%–30.6% of conceptuses) compared to controls (4.7% [p
% 0.05]; n = 43 implantation sites) (Figure 6). By contrast,
congenital abnormalities, including neural tube, heart, and
placenta abnormalities, persisted in 8.3%–15.0% of the trans-
ferred grandprogeny at E10.5 (Figures 6 and S5). No severe
abnormalities were apparent in the transferred C57Bl/6 concep-
tuses. Therefore, Mtrr deficiency results in epigenetic effectsboth on their daughter’s maternal environment and on their gam-
etes leading to defective fetal and placental development in their
grandprogeny. In support of this, we observed the persistence of
severe abnormalities, but not developmental delay or significant
frequencies of growth restriction at E10.5, in generations IV and
V derived from anMtrr+/gt maternal ancestor (Figures 7 and S6).
This further signifies that abnormal folate metabolism contrib-
utes to epigenetic inheritance through the germline.
DISCUSSION
We have conducted highly controlled experiments and genetic
crosses to show that folatemetabolism has distinct transgenera-
tional epigenetic functions that are responsible for specific
developmental processes. Remarkably,Mtrr deficiency in either
maternal grandparent resulted in a similar spectrum and fre-
quency of phenotypes in their wild-type grandprogeny. There-
fore, the initial effect of Mtrr deficiency is likely transmitted
through the germline via epigenetic factors, independent of
physiological environment and genomic sequence. The epige-
netic influences caused by Mtrr deficiency in mice leads to two
distinctive phenotypes: (1) an atypical uterine environment in
their wild-type daughters that causes growth defects in their
wild-type grandprogeny and (2) congenital malformations in their
wild-type grandprogeny due to epigenetic inheritance via the
germline, the effects of which persist for at least up to four
wild-type generations after an Mtrr-deficient maternal ancestor.
Because the folate pathway donatesmethyl groups necessary
for cellular methylation, DNA methylation was a likely epigenetic
candidate. Human polymorphisms in folate metabolic enzymes
(e.g., MTHFR 677C/T) (Castro et al., 2004; Friso et al., 2002)
or the reduction of maternal dietary nutrients (e.g., folate) during
periconceptual periods in sheep (Sinclair et al., 2007) also result
in hypomethylated or demethylated DNA in the immediate
offspring’s genome. However, none of these studies assessed
whether these effects were transmitted to subsequent genera-
tions. Changes in histone methylation are less likely than
changes in DNA methylation to explain the grandparental origin
effects simply because histones are largely replaced by prot-
amine proteins during spermatogenesis (Agell et al., 1983).
The widespread dysregulation of DNAmethylation in theMtrrgt
model likely explains thewide spectrum of phenotypes observed
in the wild-type grandprogeny. Knocking out DNA methyltrans-
ferases in conceptuses causes extensive DNA demethylation
and phenotypes, including growth restriction, developmental
delay, NTDs, placental defects, and embryonic lethality (Hata
et al., 2002; Li et al., 1992; Okano et al., 1999). These phenotypes
are reminiscent of those observed in our study and imply that
folate plays an important epigenetic role during development.
Using imprinted loci as a model for the entire genome, we
were able to show extensive epigenetic instability associated
with gene misexpression specifically in placentas of the wild-
type grandprogeny. At many of the loci assessed, the placentas
exhibited locus-specific hypermethylation in the context of
global DNA hypomethylation, which is similar to the Mthfr/
mouse that also has locus-specific methylation trends that do
not reflect genome-wide methylation trends (Chan et al., 2010;
Chen et al., 2001). The mechanism behind this finding isCell 155, 81–93, September 26, 2013 ª2013 Elsevier Inc. 87
(legend on next page)
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unknown. Because the Mtrrgt line was extensively backcrossed
to sustain genetic robustness, it was impossible to determine
the parental origin of imprinted alleles. Regardless, it is unlikely
that the alterations in DNA methylation profiles are attributed to
a failure to establish parental imprints but rather are attributed
to an inability to maintain genome-wide DNA methylation pat-
terns in imprinted and nonimprinted genes alike. This might be
a consequence of reduced methyl group availability or dysregu-
lation of methylation maintenance machinery.
We showed that congenital abnormalities in the Mtrrgt model
are caused by transgenerational epigenetic inheritance because
these phenotypes persist for four wild-type generations after the
initial Mtrrgt ancestor and occur after embryo transfer. The ge-
netic background of the Mtrrgt mouse line is an unlikely cause
of the congenital abnormalities because these defects were
never observed in the C57Bl/6 control pedigree. Although the
mechanism behind epigenetic inheritance remains unknown,
we hypothesize that some of the aberrant methylation patterns
(epimutations) caused by Mtrr deficiency escape classical
epigenetic reprogramming between generations when the
genome normally undergoes widespread demethylation. Given
the pedigree complexity, interindividual variation in methylation,
and wide spectrum of phenotypes observed here, it will be a
challenge to identify the precise epimutations that are inherited
and that cause specific phenotypes in theMtrrmodel. Moreover,
it is unclear whether the epigenome is able to stabilize in the gen-
erations following anMtrrgtmutant. In an environmental model of
transgenerational epigenetic inheritance (Anway et al., 2005),
DNA methylation defects persisted longer than the phenotype
(Stouder and Paoloni-Giacobino, 2010). Therefore, once an
epigenetic defect is generated, it may never completely revert
back to the ancestral state. This concept has important evolu-
tionary implications.
It is unlikely that the transgenerational effects observed here
are due to a cytoplasmically inherited factor such as a virus,
prion, or mycoplasma present in the embryonic stem cells
used to generate the Mtrrgt mouse line. This is because we
have preliminary data from two other independently derived
Mtrr mutant mouse lines showing similar developmental effects
as Mtrrgt mice at E10.5, including developmental delay, neural
tube, and heart defects in their wild-type grandprogeny (D.J.,
X. Zhao, J.C.C., and R.A.G., unpublished data). Other mecha-
nisms of transgenerational epigenetic effects include the inheri-
tance of small noncoding RNAs as shown in C. elegans (Grishok
et al., 2000; Vastenhouw et al., 2006). The Mtrrgt mouse model
will be extremely useful for future studies on the mechanisms
of transgenerational inheritance, including the inheritance of epi-
mutations and small noncoding RNA.Figure 5. Phenotypic Severity Is Positively Correlated with Degree of D
E10.5
(A) Diagrams of imprinted loci used as examples of epigenetic instability.
(B) Each box denotes the pedigree from which generation III placentas (n = 3
phenotypically normal [n], growth-restricted [gr], or severely affected [a]).
(C–E) CpG site-specific methylation (mean ± SEM) in the DMRs of (C)Gpr1/Zdbf2
the relative RNA levels (mean ± SEM) of the imprinted genes controlled by these D
methylation, nonparametric Mann-Whitney test comparing methylation percentag
used to compare each phenotype/pedigree to C57Bl/6. *p < 0.05, **p < 0.01, an
See also Figure S4 and Tables S3 and S5.Our finding of a grandparental, but not a direct maternal, effect
of abnormal folate metabolism appears to differ from another
study that used an independently derived Mtrrgt mouse line
(Deng et al., 2008). Deng et al. (2008) attributed small embryo
size and a ventricular septal defect in embryos at E14.5 to a
maternal effect. We ruled out a direct maternal effect at least
at E10.5 whenwe systematically controlled for the grandparental
genotypes because conceptuses from Mtrr+/+, Mtrr+/gt, and
Mtrrgt/gt mothers were similarly affected. The difference may be
due to yet-to-be explained genetic or metabolic differences or
to different stages of analysis. Gross assessment of our concep-
tuses at E14.5 showed few overt embryonic abnormalities, sug-
gesting that the severely affected conceptuses die between
E10.5 and E14.5 (N.P. and E.D.W., unpublished data).
Overall, our studies have important consequences for under-
standing and treating congenital anomalies in humans. First,
hypomorphic mutations in the MTRR gene associated with
reduced expression may lead to congenital abnormalities,
even with normal dietary folate. Second, the transgenerational
effect of Mtrr deficiency in mice suggests that the full beneficial
impact of folate fortification in humans may take more than one
generation to observe and that grandparental polymorphisms in
folate metabolism pose a risk.
EXPERIMENTAL PROCEDURES
Mice and Dissections
Embryonic stem cells with Mtrrgt allele (XG334) were purchased from
BayGenomics (http://www.mmrrc.org/catalog/overview_BG.php) and in-
jected into C57Bl/6 blastocysts using standard procedures at BayGenomics.
After confirmation of germline transmission of Mtrrgt allele, the progeny were
backcrossed to C57Bl/6 mice (http://jaxmice.jax.org) R 8 generations to
become generation I. Mice in theMtrr+/gt intercross andmaternal effect studies
(Figures 2A and S1 and Table S1) were backcrossed only six generations.
Noon of the day the vaginal plug was detected was considered E0.5. Embry-
onic somite staging was determined according to e-Mouse Atlas Project
(http://www.emouseatlas.org). Conceptuses were scored for phenotypes,
photographed, weighed, and snap frozen for storage. All experiments were
performed in accordance with the Canadian Council on Animal Care and the
University of Calgary Committee on Animal Care (protocol number M06109)
and UK Government Home Office licensing procedures.
Diet
Mice were fed a normal breeding diet ad libitum from weaning onward. For
more information, see the Extended Experimental Procedures and Table S4.
Genotyping
A three-primer PCR reactionwas used to detect the presenceor absence of the
gt in theMtrr allele. Two primers, a (50-GAGATTGGGTCCCTCTTCCAC) and b
(50-GCTGCGCTTCTGAATCCACAG), flanked the gt insertion site and detected
thewild-type band (272 bp) (Figure 1B). Primer a, together with primer c (50- CGysregulated DMR Methylation and Gene Expression in Placentas at
–11) were selected for analysis in panels (C)–(E) and their phenotype (e.g.,
, (D) Igf2/H19, and (E)Grb10 loci as determined by pyrosequencing followed by
MRs. Values were compared to C57Bl/6 controls. Statistical analysis: for DNA
es at each CpG site to C57Bl/6; for gene expression, independent t tests were
d ***p < 0.005.
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Figure 6. EpigeneticMechanism ofMtrrDeficiency Leads toDistinct
Phenotypes in their Grandprogeny Caused by an Atypical Uterine
Environment in Their Daughters or Epigenetic Inheritance
Phenotypic frequencies at E10.5 resulting from the transfer of wild-type pre-
implantation embryos derived from an Mtrr+/gt MGM and Mtrr+/+ mother
(center) or an Mtrr+/gt MGF and Mtrr+/+ mother (right) into a B6D2F1 pseudo-
pregnant recipient female. C57Bl/6 embryos were transferred as a control
(left).
(A and B) Data are represented (A) graphically as the number of phenotypes/
litter and (B) as the average number of phenotypically affected conceptuses/
litter (± SEM) followed by the percentage of total conceptuses as-
sessed in brackets, unless otherwise indicated. GR, growth-restricted; GE,
growth enhanced; Dev’tal, developmental. Independent comparison of
phenotypic frequencies from each pedigree to the C57Bl/6 was completed
using Mann-Whitney tests. ap = 0.05, *p < 0.05, and **p < 0.01. Pedigrees:
circle, female; square, male; blue outline, C57Bl/6 mice; black outline, Mtrr
90 Cell 155, 81–93, September 26, 2013 ª2013 Elsevier Inc.ACTTCCGGAGCGGATCTC), which annealed to the gt, detected the mutant
band (383 bp). PCR parameters: 30 s at 95C, 1 min at 62C, and 1 min at
72C for 30 cycles. DNA samples were obtained from ear or yolk sac tissue.
DNA and RNA Extraction
For Mtrr transcript analysis, total RNA extraction from adult organs was
completed using TRIzol reagent according to manufacturer’s instructions
(Invitrogen). For transcript analysis of imprinted genes, whole placentas and
embryos at E10.5 were homogenized using lysing matrix D beads (MP Bio-
medicals). Total RNA extraction was completed using the GenElute Mamma-
lian Total RNAMiniprep Kit (Sigma) or AllPrep DNA/RNAMini Kit (QIAGEN). All
extracts were treated with DNase I (Fermentas).
qRT-PCR
Reverse-transcription reactions were performed with the RevertAid H Minus
First Strand complementary DNA (cDNA) Synthesis Kit (Fermentas) by using
2–5 mg of RNA in a 20 ml reaction according to manufacturer’s instructions.
PCR amplification was conducted using MESA SYBR Green qPCRMasterMix
Plus (Eurogentec) on an Applied Biosystems 7500 system or a Roche LightCy-
cler 480 System. Transcript levels were normalized to Actb and/or Hprt RNA
levels, and the fold change was quantified using the standard curve method.
cDNA levels in C57Bl/6 placentas were normalized to 1. Experiments were
conducted in triplicate with at least three biological replicates. For primer se-
quences, refer to Table S5.
Total Homocysteine Concentrations
Total homocysteine in plasmawasmeasuredby theBiochemicalGeneticsUnit,
Department of Clinical Biochemistry, Cambridge University Hospitals NHS
Foundation Trust using underivatized LC-MS/MS (Waters Acquity LC system
and Quattro Premiere mass spectrometer) operated in electrospray ionization
positive mode. A deuterated internal standard, d8-homocystine, was added
to the plasma, followed by reduction of disulfides with dithiothreitol (Magera
et al., 1999; Weaving et al., 2006). Calibrators were prepared by spiking normal
plasma with a range of known homocysteine concentrations. Fifty mL of d8-ho-
mocystine was added to 50 ml of plasma, which, when reduced, gave twice as
much homocysteine. The mixture was reduced with dithiothreitol, and proteins
were precipitated with acetonitrile and 0.1% formic acid. The samples were
centrifuged and transferred to 96-well plates, and the supernatant was injected
into the tandemmass spectrometer via a cyano LC column (Supelcosil LC-CN).
Multiple reactionmonitoring (MRM)wasused toquantify the total homocysteine
against a standard curve.Quality control sampleswere run at two levels in every
batch, which haddesigned acceptance limits before the resultswere accepted.
DNA Methylation Analysis
Tissue was snap frozen immediately after phenotypic scoring and stored at
80C. DNA extraction from all samples occurred simultaneously to reduce
sample variability. Global DNA methylation was measured using the Super-
Sense Methylated DNA Quantification Kit (Epigentek) or the MethylFlash
Methylated DNA Quantification Kit (Fluorometric) (Epigentek) according to
manufacturer’s instructions. Briefly, genomic DNA extracted from tissue was
exposed to a fluorescently labeled antibody against 5-methylcytosine (5mC),
and the fluorescence intensity was quantified with a FLUOstar OPTIMA fluo-
rescence plate reader (BMGLABTECH) at 540EX/590EM nm. Global 5mC levels
were calculated as a percentage of total cytosine in DNA and normalized to 1.
Four to eight biological replicates were used per category tested.
Tomeasure relative CpGmethylation at imprinted DMRs, genomic DNAwas
bisulphite treated using an Imprint DNA Modification Kit (Sigma). 50 ng of bi-
sulphite-converted DNA was used as a template for PCR, together with
0.2 mMof each biotinylated primer and 0.25 units of HotStarTaq DNA Polymer-
ase (QIAGEN) or TrueStart* Taq DNA Polymerase (Fermentas). Refer to Table
S5 for primer sequences. PCR parameters: 30 s at 95C, 30 s at the annealing
temperature (Table S5), and 45 s at 72C for 40 cycles. PCR products weremouse line; red outline, B6D2F1 hybrid mice; white fill, Mtrr+/+; half black/half
white fill, Mtrr+/gt.
See also Figure S5.
Figure 7. Congenital Malformations Are
Transmitted at Least up to Four Wild-Type
Generations after an Mtrr+/gt Maternal
Ancestor
(A and B) The phenotypic frequencies within wild-
type litters at E10.5 from generations III, IV, and V
derived from an Mtrr+/gt MGM or Mtrr+/gt MGF
compared to C57Bl/6 pedigrees. Data are repre-
sented (A) graphically as the number of pheno-
types/litter and (B) as the average number of
phenotypically affected conceptuses/litter (±SEM)
for each pedigree followed by the percentage of
total conceptuses in brackets. Phenotypic fre-
quencies/pedigree were independently compared
to C57Bl/6 using Mann-Whitney test. *p < 0.05,
**p < 0.01, and ***p < 0.001. See also Figure S6.purified using Streptavidin Sepharose High Performance columns (GE Health-
care) and hybridized to the sequencing primer using a PyroMark Q96 Vacuum
Prep Workstation (QIAGEN). Further sequencing was performed using the
PyroMark Gold Reagents kit (QIAGEN) on a PyroMark MD Pyrosequencing
System (QIAGEN). The mean CpG methylation was calculated using at least
four biological replicates and two technical replicates.
Embryo Transfers
Using M2 media (M7167, Sigma), embryos were flushed at E3.25 from uteri of
Mtrr+/+ females (derived from one Mtrr+/gt parent) mated with C57Bl/6 males.
Nohormoneswereused. Theembryoswere cultured inKSOM(MR-121-D,Milli-
pore) microdrops covered with mineral oil (ES-005-C, Millipore) at 37C for no
more than 30 min before transferring them into uteri of E2.5 pseudopregnant
[C57Bl/6 x DBA/2] F1 hybrid (B6D2F1) recipient females (http://www.criver.
com). C57Bl/6 embryos were transferred as controls. B6D2F1 females, which
have 50% genetic similarity to C57Bl/6 mice, were used because C57Bl/6
mice are notoriously poor recipients. Donor and recipient females were
7–10weeks old. Embryoswere transferred regardless of appearance, and litters
were never pooled. Transferred litters were dissected at E10.5, the timing of
which corresponded to the staging of the recipient female (Ueda et al., 2003).
Statistical Analysis
Statistical analyses were performed using GraphPad Prism 6 software. Para-
metric data (e.g., litter sizes, mRNA expression, homocysteine concentrations,
embryo lengths, placenta weights, and global DNA methylation levels) were
analyzed using independent unpaired t tests. Global DNAmethylation percent-
ages were normalized by arc sine transformation prior to t tests. Nonpara-
metric data (e.g., phenotypic frequencies and bisulfite pyrosequencing data)
were analyzed using a Mann-Whitney or Kruskal-Wallis test. p < 0.05 was
considered significant.
Equipment and Software
A Zeiss SteREODiscovery V8microscopewith an AxioCamMRc5 camera and
AxioVision 4.7.2 software (Carl Zeiss) imaging software program were used toobtain embryo images and embryo crown-rump lengths. PCR and pyrose-
quencing primers were designed using Primer3 v0.4.0 software (Rozen and
Skaletsky, 2000) and Pyromark Assay Design 2.0 software (QIAGEN), respec-
tively. Graphs were generated using GraphPad Prism 6 software. Figures were
constructed using Canvas X software.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and five tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2013.09.002.
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